LBT Innovations strikes $0.7M deal with NovaCina for APAS Independence Instrument
Adelaide, Australia: LBT Innovations Limited, a pioneer in AI-driven microbiology automation, has announced a significant contract with NovaCina, a Perth-based CDMO. The deal, valued at over $0.7 million, includes the sale of an APAS® Independence instrument equipped with APAS® PharmaQC…